Hewmun Lau

Principal @ Broadview Ventures Inc

About

Life science business professional with broad experience in venture, biotech/pharmaceutical industry, strategy consulting and R&D. Currently a Principal at Broadview Ventures, a fund focused on mission-investing in Cardiovascular Disease and Stroke. Prior experience include multiple operational roles within Merrimack Pharmaceuticals, strategy consulting with biotech and large pharma clients on business issues ranging from market opportunity assessments to business development and licensing. Early career include biomedical lab research roles in both academia and industry. Education include MBA from MIT Sloan School of Management, M.S. from Harvard-MIT Program in Health Sciences & Technology and B.S. from Brandeis University.

Country

United States

City

Greater Boston

Industry

Venture Capital & Private Equity

Skill

Investments, Strategic Planning, Cardiovascular Disease, Lifesciences, Genetics, Data Analysis, Business Strategy, Drug Discovery, Financial Modeling, Life Sciences, Clinical Trials, Laboratory, Management Consulting, Business Development, Biotechnology, Strategy

Experience

Principal

Broadview Ventures Inc

2019-5 - Present · 7 yrs 5 mos

Greater Boston Area

Responsible for the day-to-day investment activities at Broadview Ventures, including identification and screening of new opportunities, due diligence, negotiation of deal structure, and portfolio company board involvement. Broadview is a mission-driven fund whose primary investment goal is to improve human health in the areas of cardiovascular disease and stroke. With 37 such investments since 2008, Broadview has considerable experience in the seed/early-stage space.

Member Board of Directors

Mosanna Therapeutics

2025-6 - Present · 1 yr 4 mos

Principal

Longview Ventures

2019-5 - Present · 7 yrs 5 mos

Boston, Massachusetts, United States

Board Observer

Basking Biosciences

2020-8 - Present · 6 yrs 2 mos

Research Triangle Park, North Carolina

Basking Biosciences, Inc. is developing the first reversible thrombolytic therapy for Acute Ischemic Stroke (AIS). Basking is focused on exploiting the properties of RNA biology to develop aptamers with high affinity and specificity against proteins involved in coagulation and hemostasis.

Board Observer

Antag Therapeutics

2020-3 - 2024-11 · 4 yrs 9 mos

Copenhagen, Denmark

Antag Therapeutics is a Copenhagen-based preclinical stage biotechnology company focused on developing therapies for dietary-related metabolic diseases. The company’s current lead therapy is a glucose-dependent insulinotropic peptide receptor (GIPR) antagonist for inducing weight loss in obese patients with Type-2 Diabetes.

Board Observer

Renovacor

2020-9 - 2021-9 · 1 yr 1 mo

Philadelphia, Pennsylvania

Renovacor is a preclinical stage biotechnology company whose mission is to develop improved therapies for genetically derived cardiovascular diseases. The company is currently developing a gene therapy for a rare, familial form of dilated cardiomyopathy due to mutation in the BAG3 gene.

Director of Corporate Development

Merrimack

2018-2 - 2019-3 · 1 yr 2 mos

Cambridge, MA

Associate Director, New Product Planning and Business Development

Merrimack

2017-2 - 2018-2 · 1 yr 1 mo

Cambridge, MA

Senior Manager, Commercial Analytics - ONIVYDE

Merrimack

2015-10 - 2017-2 · 1 yr 5 mos

Cambridge, MA

- Play key role in building commercial analytic capabilities for Merrimack's first product launch in oncology - Analytics lead for Northeast and Southeast Regions, act as strategic thought partner with Field to develop actionable business recommendations in order to drive ONIVYDE adoption - Supported cross-functional teams in Marketing, Product Availability and Market Access, Commercial IT, among others, in critical business decision-making, Communicate key findings to a broad range of key stakeholders

Senior Consultant (Life Sciences Practice)

Navigant

2012-9 - 2015-10 · 3 yrs 2 mos

Greater Boston Area

Strategic life science consultant with experience across multiple therapeutic areas and project types, including: - Commercial opportunity assessments and forecasting - New product launch planning - Competitive assessments - BD&L opportunity assessments Skills include primary and secondary market research, forecasting, project management